Prevagen Faces Lawsuit

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

HEALTHWATCH - A company behind the dietary supplement, Prevagen, is now under fire for misleading its customers.

Prevagen has been marketed as a drug that can improve memory, costing a person as much as $69 per bottle. Two government agencies have filed a lawsuit against Quincy Bioscience because they say it doesn't work. The legal document also claims that the group's aggressive marketing tactics target a vulnerable group, older Americans.

Quincy Bioscience has called the allegations unfounded and inaccurate, but documents show the FDA conducted inspections at two locations belonging to Quincy's parent company just this past October and November. The agency declined to comment further because as it put it, the matter remains open.

Segment Sponsored by: Mercy Health System

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.